Biltema Foundation donates SEK 260 million to research on revolutionary method for cancer treatment
When patients undergo cancer treatment today, up to 40% of the cancers prove resistant to current standard care. The limitations are often due to the inaccessibility of the tumors, and in the event of treatment, the surrounding tissue would have been excessively damaged1.
Researchers at Lausanne University Hospital have developed a new type of radiotherapy called FLASH. The intensity of the radiation enables the same radiotherapeutic effect on the tumor, but administrated for milliseconds instead of minutes. With this method, the radiation is directed at the tumor with much higher precision, and the surrounding tissue is affected to a considerably lesser extent.
The phenomenon that FLASH radiotherapy is based on was discovered in 2014, and already in 2018, the first patient was treated successfully with this method. With funding from, among others, the donation from Biltema Foundation, the goal is now to further develop this form of treatment and continue to cure cancer patients.
Read more about FLASH radiotherapy here.
- lausanneuniversityhospital.com, Tackling cancer treatment resistance with FLASH, accessed 2021–02–23 from https://www.lausanneuniversityhospital.com/tackling-cancer-treatment-resistance-with-flash.